Use of defibrotide for the inhibition of heparanase

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/711 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2655522

A study has been carried out to verify the effect of Defibrotide on the activity and expression of Heparanase enzyme on myeloma tumor cells (U266) and human microvascular endothelial cells (HMEC). The study has demonstrated that defibrotide can be effectively used for the manufacture of a medicament for the treatment of diseaseses which are positively affected by the inhibition of Heparanse and/or by the downregulation of Heparanse gene expression, such as diabetes.

Selon l'invention, une étude a été réalisée pour vérifier l'effet du défibrotide sur l'activité et l'expression d'une enzyme, l'héparanase, dans des cellules de myélome (U266) et des cellules épithéliales de capillaires humains (Human Microvascular Endothelial Cells; HMEC). L'étude a démontré que le défibrotide peut être utilisé efficacement pour la fabrication d'un médicament destiné au traitement de maladies, le diabète par exemple, dans lesquelles un effet positif est obtenu par l'inhibition de l'héparanase et/ou par la régulation négative de l'expression du gène de l'héparanase.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of defibrotide for the inhibition of heparanase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of defibrotide for the inhibition of heparanase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of defibrotide for the inhibition of heparanase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1474342

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.